Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC2112 Fibroblast Growth Factor (1-10)

Fibroblast growth factor fragment

96927-63-8
DCC2113 Fibronectin Adhesion-promoting Peptide

Potent macrophage activator, enhancing interleukin 12-dependent interferon gamma production by lipopolysaccharide-stimulated mouse splenocytes, exerting an antiviral action against HSV-1 with the independent pathways of IFN-alpha

125720-21-0
DCC2114 Fibronectin Cs1 Peptide

Cell-adhesive octapeptide as the authentic sequence within intact fibronectin, mediating OSCC cell spreading, migration, and invasion, regulating IL-17A levels and mechanical allodynia after peripheral nerve injury

136466-51-8
DCC2115 Finafloxacin Hydrochloride

Antibacterial agent, expressing enhanced activity at acidic pH

209342-41-6
DCC2116 Fischerin

Natural potent cytotoxic agent

134822-63-2
DCC2117 Fitc-sulfono-γ-aa Peptide

Fluorescent protein-protein interaction (PPI) inhibitor

DCC2118 Fk1012-a

Highly potent membrane-permeable ligand of the immunophilin FKBP12, creating a new composite FKBP12-FK506 surface and inactivating calcineurin, a Ca calmodulin-dependent protein phosphatase

152406-17-2
DCC2119 Fk-3657

Novel non-peptide bradykinin (BK)-B2 receptor antagonist

167838-64-4
DCC2120 Fkbp12-in-q2

Novel Inhibitor of FKBP12

392313-31-4
DCC2121 Flaviviruses-inhibitor-i

Specific inhibitor of several viruses belonging to the family of flaviviridae

392237-10-4
DCC2122 Flemingin A

Natural anticancer and antioxidant

18296-58-7
DCC2123 Flg249

Novel, potent, orally active, and nonsteroidal farnesoid X receptor (FXR) antagonist with propensity for accumulation and responsiveness in ileum

DCC2124 fli-28

Novel inhibitor of general secretion in early stage; FLI-06 analogue twice as active as FLI-06

433244-15-6
DCC2125 Flll11

Curcumin analogue, exhibiting enhanced growth-suppressive activity and inhibiting AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells

DCC2126 Flll12

Curcumin analogue, exhibiting enhanced growth-suppressive activity and inhibiting AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells

DCC2127 flll62

Inhibitor of STAT3 phosphorylation and apoptotic promoter of human renal cell carcinoma and melanoma cell lines

1252589-98-2
DCC2128 Flortanidazole

Tumour hypoxia probe

1070878-63-5
DCC2129 Flt3 Inhibitor 17

Novel FLT3 inhibitor, displaying potent inhibitory activity against the FLT3-ITD mutant (IC 50 = 0.8 nM) and good selectivity over c-KIT kinase (over 500-fold), selectively inhibiting the proliferation of FLT3-ITD-positive AML cell lines MV4-11 (IC 50 = 2

DCC2130 Flt3 Inhibitor Iv

Novel potent ATP-competitive inhibitor of Flt3

819058-89-4
DCC2131 Flt3-in-50

Novel selective and efficacious inhibitor of FLT3 mutations

DCC2132 fluacrypyrim

Novel STAT3 activation inhibitor, induces cell cycle arrest and apoptosis in cancer cells harboring constitutively-active STAT3

229977-93-9
DCC2133 Flubendiamide

The first phthalic acid diamide insecticide, impairs neuronal calcium signalling in the honey bees antennae

272451-65-7
Page 1318 / Total 1557 FirstPrevNextLastGoto